Pain in the Access is a publication is about the business strategy of biopharma, with a focus on value, access, and evidence.
Articles will focus on topics like:
How coverage, pricing, and evidence influence business strategies in pharma
What lessons we can learn from other industries (like tech and retail)
The impact of new technologies like AI on the way the industry operates
Implications for manufacturers, payers, and patients as the market evolves
I’ve spent 15 years in biopharma strategy, pricing, access, and evidence. This newsletter is my way of processing where the industry is heading.
Nothing makes me happier than thinking about this industry and having conversations with like-minded folks. If anything here sparks a thought, I’d love to hear from you!
All the best,
John Jarvis
